Table 5.
Least used items in the VDI and CDA in patients with vasculitis
| Items not used | Items used <1% |
|---|---|
| VDI: | |
| Second episode fresh loss of pulses in one limb*† | Deforming/erosive arthritis* |
| Second cerebrovascular accident* | Cardiomyopathy |
| Blindness other eye | Claudication |
| Chronic peritonitis*† | Gut infarction/resection |
| Major psychosis*† | Major tissue loss† |
| Mesenteric insufficiency/pancreatitis* | Marrow failure |
| Minor tissue loss | Myocardial infarction* |
| Oesophageal stricture/upper GI surgery*† | Pleural fibrosis |
| Osteomyelitis† | Pulmonary infarction |
| Pericarditis ≥3 months/pericardectomy*† | Seizures*† |
| Pulmonary hypertension† | Transverse myelitis* |
| Subsequent major tissue loss*† | |
| Subsequent myocardial infarction*† | |
| CDA: | |
| Auricular cartilage deformity left | Auricular cartilage deformity right |
| Cervical cancer | Bladder cancer |
| Cholesteatoma left | Continuous oxygen dependency |
| Cholesteatoma right | Gangrene with permanent tissue loss |
| Chronic peritonitis | Gut infarction/resection |
| Haematopoetic malignancy | Hepatic fibrosis |
| Mesenteric insufficiency/pancreatitis | Impaired fasting glucose |
| Myelodysplastic syndrome | Optic nerve oedema left |
| Oesophageal stricture/surgery | Pericarditis or pericardiectomy |
| Optic nerve oedema right | Pleural fibrosis |
| Osteomyelitis | Pseudotumour left eye |
| Percutaneous coronary intervention | Pseudotumour right eye |
| Pulmonary hypertension | Pulmonary infarction |
| Refractory cytopenia | Retinal artery occlusion left |
| Retinal artery occlusion right | Retinal changes left |
| Retinal vein occlusion right | Retinal vein occlusion left |
| Scleral perforation left | Scleral thinning left |
| Scleral perforation right | Scleral thinning right |
| Second cerebrovascular accident | Second episode of absent pulses in one limb |
| Subsequent major tissue loss | Tissue loss (includes major and minor) |
| Third degree AV block | |
| Transverse myelitis | |
| Vena caval filter |
For VDA, items used <1%. For CDA, items used <0.05%
*
Items not used in the WGET trial cohort, n=180 patients.9
†
Items not used in the long-term follow-up (5 year VDI) of the EUVAS cohorts, n=339 patients (EUVAS trial physicians, unpublished results).
AV, atrioventricular; CDA, Combined Damage Assessment Index; EUVAS, European Vasculitis Study Group; GI, gastrointestinal; VDI, Vasculitis Damage Index; WGET, Wegener’s Granulomatosis Etanercept Trial.